San Francisco, CA · Founded 2019 · Privately Held (backing)
Developer of therapeutic enzymes designed for degrading molecular damage associated with aging. Revel Pharmaceuticals is based in San Francisco, CA and was founded in 2019. It was valued at $15 million at its early-stage round in Mar 2022, the last priced event on record. It has raised $14.7 million across 3 recorded rounds; the latest was a $5.8 million early-stage round in Feb 2022.
PMV mark · valuation
$15.0M
Oct 2026
Priced at
its early-stage round
Mar 2022
Total raised
$14.7M
Last round
Early Stage VC
Feb 2022
Cap table — not yet on record
Revel Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Revel Pharmaceuticals with a free account
·Watch Revel Pharmaceuticals: the Monday email on marks, rounds and moves
Where does Revel Pharmaceuticals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Revel Pharmaceuticals's 3 recorded funding rounds.
